[go: up one dir, main page]

MX2013006658A - Métodos para producir y usar brasinoesteroides para promover el crecimiento, la reparación y mantenimiento del músculo esquelético y la piel. - Google Patents

Métodos para producir y usar brasinoesteroides para promover el crecimiento, la reparación y mantenimiento del músculo esquelético y la piel.

Info

Publication number
MX2013006658A
MX2013006658A MX2013006658A MX2013006658A MX2013006658A MX 2013006658 A MX2013006658 A MX 2013006658A MX 2013006658 A MX2013006658 A MX 2013006658A MX 2013006658 A MX2013006658 A MX 2013006658A MX 2013006658 A MX2013006658 A MX 2013006658A
Authority
MX
Mexico
Prior art keywords
repair
skin
maintenance
methods
skeletal muscle
Prior art date
Application number
MX2013006658A
Other languages
English (en)
Inventor
Ilya Raskin
Debora Esposito
Slavko Komarnytsky
Thirumurugan Rathinasabapathy
Castillo Leonel Rojo
Original Assignee
Univ Rutgers
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rutgers filed Critical Univ Rutgers
Publication of MX2013006658A publication Critical patent/MX2013006658A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/63—Steroids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/004—Expansion of ring B by one atom, e.g. B homo steroids

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La descripción se refiere a métodos para usar compuestos brasinoesteroides, que incluyen los definidos en la fórmula I o un derivado de estos, para inducir un estado anabólicamente favorable para el crecimiento, reparación y mantenimiento del músculo esquelético y la piel.
MX2013006658A 2010-12-13 2011-12-13 Métodos para producir y usar brasinoesteroides para promover el crecimiento, la reparación y mantenimiento del músculo esquelético y la piel. MX2013006658A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42254810P 2010-12-13 2010-12-13
PCT/US2011/064663 WO2012082750A1 (en) 2010-12-13 2011-12-13 Methods of producing and using brassinosteroids to promote growth, repair and maintenance of skeletal muscle and skin

Publications (1)

Publication Number Publication Date
MX2013006658A true MX2013006658A (es) 2013-11-04

Family

ID=46245074

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013006658A MX2013006658A (es) 2010-12-13 2011-12-13 Métodos para producir y usar brasinoesteroides para promover el crecimiento, la reparación y mantenimiento del músculo esquelético y la piel.

Country Status (8)

Country Link
US (1) US20140128357A1 (es)
EP (1) EP2651221A4 (es)
JP (1) JP2013545809A (es)
CN (1) CN103354717A (es)
AU (1) AU2011343970A1 (es)
CA (1) CA2821501A1 (es)
MX (1) MX2013006658A (es)
WO (1) WO2012082750A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2902768A1 (en) * 2013-03-14 2014-10-02 Aquinox Pharmaceuticals (Canada) Inc. Ship1 modulators and methods related thereto
CN105237603B (zh) * 2015-10-28 2017-03-15 湖南科瑞生物制药股份有限公司 一种以豆甾醇为原料合成胆固醇的方法
FR3078252B1 (fr) * 2018-02-28 2020-08-14 Biophytis Phytoecdysones pour leur utilisation dans la prevention de la perte de force musculaire lors d’une immobilisation
CN110896747B (zh) * 2019-10-22 2021-10-22 韶关学院 一种利用油菜素唑控制采后菠萝黑心病的方法
WO2022011393A1 (en) 2020-07-08 2022-01-13 Shaman Naturals, Llc Compositions for preventing and treating diabetes
CN115645416B (zh) * 2022-10-13 2023-08-15 贵州医科大学 Calvasterol A在制备治疗肝纤维化药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6017794B2 (ja) * 1980-05-16 1985-05-07 ア−ス製薬株式会社 新規ステロイド類
JPS5890578A (ja) * 1981-11-24 1983-05-30 Sumitomo Chem Co Ltd 新規ステロイド類の製造法
US6987025B1 (en) * 1999-02-11 2006-01-17 The Arizona Board Of Regents On Behalf Of The University Of Arizona Dwf4 polynucleotides, polypeptides and uses thereof
US6063731A (en) * 1999-03-30 2000-05-16 Agritope, Inc. Brassinosteroid analogs useful as plant growth regulators
US6239073B1 (en) * 1999-03-30 2001-05-29 Exelixis Plant Sciences, Inc. Brassinosteroid analogs useful as plant growth regulators
US8377915B2 (en) * 2006-05-09 2013-02-19 Rutgers, The State University Of New Jersey Methods for treating or preventing disorders using ecdysteroid compositions
JP4799335B2 (ja) * 2006-09-19 2011-10-26 株式会社ノエビア 保湿剤、細胞賦活剤、コラーゲン産生促進剤、ヒアルロン酸産生促進剤、抗酸化剤及び中性脂肪蓄積抑制剤
CN103214546B (zh) * 2012-01-18 2018-11-23 成都新朝阳作物科学有限公司 天然芸苔素内酯类似物的应用

Also Published As

Publication number Publication date
EP2651221A1 (en) 2013-10-23
CA2821501A1 (en) 2012-06-21
AU2011343970A1 (en) 2013-07-04
WO2012082750A1 (en) 2012-06-21
CN103354717A (zh) 2013-10-16
JP2013545809A (ja) 2013-12-26
EP2651221A4 (en) 2014-07-23
US20140128357A1 (en) 2014-05-08

Similar Documents

Publication Publication Date Title
JOP20210065A1 (ar) عملية لتحضير 5- فلورو-1h- بيرازولوبيريدينات مستبدلة
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
IN2014CN04907A (es)
MX2009014104A (es) Metodos para sintetizar cinacalcet y sales del mismo.
UA103794C2 (en) Liposome composition
TN2013000347A1 (en) Production method of optically active dihydrobenzofuran derivative
MX2013006658A (es) Métodos para producir y usar brasinoesteroides para promover el crecimiento, la reparación y mantenimiento del músculo esquelético y la piel.
PH12015500376A1 (en) Novel bicyclic pyridinones
PH12014501258A1 (en) Pyrazolopyridine derivatives, preparation process therefor and therapeutic use thereof
MY163339A (en) A method of producing ingenol-3-angelate
PH12015501293B1 (en) Imidazopyridazine derivatives as gabaa receptor modulators
IN2014KN01062A (es)
IN2014DN01609A (es)
IN2012DN05081A (es)
GEP20146196B (en) Disubstituted tetrahydofuranyl compounds as antagonists of bradykinin b1 receptor
UA106988C2 (uk) Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та необхідні проміжні сполуки магнію
PH12015500061A1 (en) Method for preparing substituted triazolopyridines
PH12016501704B1 (en) Method for producing 2-acyliminopyridine derivative
GB2523674A (en) Compounds as inhibitor of DNA double-strand break repair, methods and applications thereof
MX2013005825A (es) Benzoxazepinas como inhibidores de objetivo de rapamicina en mamiferos (mtor) y metodos de uso y fabricacion.
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
HK1189454A (en) Methods of producing and using brassinosteroids to promote growth, repair and maintenance of skeletal muscle and skin
MY152069A (en) Substituted 3-benzofuranyl-indol-2-one-3-acetamidopiperazine derivatives, preparation threof, and therepeutic use thereof
IN2012DN00346A (es)
MX2013005624A (es) Nuevos derivados de indolizina, su preparacion y su aplicacion en terapeutica.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal